Skip to content

Next Gen ECG Board

Next Generation M540 ECG Board - Next Generation M540 ECG Board

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58269
Enrollment
65
Registered
2025-12-17
Start date
2026-01-18
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients admitted at a cardio thorasic Intensive care for hemodynamic monitoring Patients admitted for hemodynamic monitoring

Interventions

A Draeger Infinity M540 patient monitor with modified hardware for ECG data processing

Sponsors

Drägerwerk AG & Co. KGaA
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients admitted in the intensive care Patients 18 years and above for whom cardiac and/or hemodynamic monitoring is indicated. Subjects hospitalized for any reason, with or without having undergone surgery, and monitored by IACS as standard of care in the study site. Patients presenting with a permanent pacemaker implanted IEC approved, written informed consent obtained from the subject and/or the subject’s legal representative prior to starting the study data recording period and transferring any data from the Infinity Acute Care System to the sponsor.

Exclusion criteria

Exclusion criteria: Patients below 18 years of age (pediatrics, neonates) Patient in hyperbaric chamber Patient in environment containing MRI equipment

Design outcomes

Primary

MeasureTime frame
The primary endpoint is to determine if it is adequate to discern noise issues and environmental effects when the investigational device is used in a hospital setting.

Secondary

MeasureTime frame
The secondary endpoint for data collected from participants with pacemakers enrolled in the second group, the type of pacemaker and settings will be observed and the position of pace pulses annotated relative to QRS complex (paced rhythm representing ventricular depolarization). Collected study data will be processed through an analysis software that pulls apart ECG channels and Pace channels, then data will be compared to current performance standards in commercially cleared, CE marked version of the M540 patient monitor.

Countries

Netherlands

Contacts

Public ContactAV Valentin

Draeger Medical Systems, Inc.

alyssa.valentin@draeger.com+1 (978) 409-0664

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)